US-based biotechnology company Rallybio has entered a definitive agreement to acquire Candid Therapeutics through a merger ...

Kairos Pharma has signed a binding agreement to acquire exclusive worldwide rights to CL-273 from Celyn Therapeutics.

New drugs and lucrative markets in the US remain crucial to Europe’s pharma sector, as governments approach closer trade with Asia.

Both Novo and obesity market rival Eli Lilly have outlaid significant funds to ensure future demand for oral weight loss drugs is met.

BioMarin Pharmaceutical has received FDA approval for its sBLA for Palynziq’s use in adolescents aged 12 years and above with ...

The EMA's CHMP has issued a positive opinion recommending the approval of Dupixent in the EU for paediatric patients with CSU ...

BioMarin’s Voxzogo (vosoritide) won FDA approval in paediatric achondroplasia in November 2021 and secured a label extension ...

Novo Nordisk and Vivtex are to co-develop next-generation oral biologic therapies to treat obesity, diabetes and related ...

Quotient Sciences has extended its commercial partnership with Ipsen, focusing on the production of Sohonos for FOP.

Asahi Kasei has signed a definitive agreement to acquire all issued shares of Aicuris Anti-infective Cures for approximately ...

AbbVie has announced plans to invest $380m to construct two new active pharmaceutical ingredient (API) manufacturing ...

IQVIA Holdings has signed an agreement to acquire selected discovery service assets from Charles River Laboratories, aiming to expand its end-to-end capabilities.